Dublin, Feb. 06, 2025 (GLOBE NEWSWIRE) — The “Clinical Trial Biorepository & Archiving Solutions Market Size, Share & Trends Analysis Report By Service, By Product, By Phase, By Region, And Segment Forecasts, 2025 – 2030” report has been added to ResearchAndMarkets.com’s offering.
The global clinical trial biorepository & archiving solutions market size is expected to reach USD 7.01 billion by 2030, registering a CAGR of 8.18% from 2025 to 2030. This is mainly due to the increasing importance of biological sample management in clinical trials and the desire to streamline data collection and reporting. In addition, the expansion of precision, personalized, and genomic medicine, increased R&D spending and efforts to make data gathering & reporting easier by employing software like the Laboratory Information Management System (LIMS) to manage laboratory samples are all key factors driving the industry growth.
Multiple regulatory agencies advise and develop best practices in biorepository operations. The International Society for Biological and Environmental Repositories has strengthened its position in the standardization of bio-storage procedures on a global level. The College of American Pathologists established the first biorepository accreditation scheme that adheres to stringent regulations to standardize biorepository practices. Biorepository standards for competence, impartiality, and consistent operation for bio storage have been issued by the International Organization for Standardization (ISO-20387).
The U.S. FDA has established Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), GDP, and Good Tissue Practice (GTP), which contain the elements associated with the packing and storage of drug products. In addition, the COVID-19 pandemic has created several growth opportunities for local companies. To enhance their foothold in the industry, key companies are adopting various plans and policies to gain a more significant revenue share in the global market. The important step key players can incorporate partnering with relevant third-party vendors. It can be achieved through proper communication and adjustments in the frequency and volume of clinical trial biorepository and archiving solutions.
Clinical Trial Biorepository & Archiving Solutions Market Report Highlights
- In 2024, the biorepository services segment dominated the market, accounting for a revenue share of 66.91%. The segment growth can be attributed to the rise in R&D of advanced therapies, such as regenerative medicine, personalized medicine, and cancer genomic studies, which require effective storage, distribution, and processing solutions.
- On the basis of the product segment, the market is segmented into preclinical products and clinical products. In 2024, the clinical products segment accounted for the largest revenue share of 63.40% in the clinical trial biorepository & archiving solutions market.
- On the basis of phase segment, the market is segmented to preclinical, phase I, phase II, phase III, and phase IV. The preclinical segment accounted for the largest revenue share of 36.60% in 2024. The segment growth can be growing emphasis on data integrity & transparency.
- North America clinical trial biorepository & archiving solutions market accounted for the largest share of 47.99% in 2024. The increase in the number of clinical trials and several market players in the region aiming to expand their existing services are further contributing to the growth of clinical trial biorepository & archiving solutions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 192 |
| Forecast Period | 2024 – 2030 |
| Estimated Market Value (USD) in 2024 | $4.38 billion |
| Forecasted Market Value (USD) by 2030 | $7.01 billion |
| Compound Annual Growth Rate | 8.1% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1. Research Methodology and Scope
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Clinical Trial Biorepository & Archiving Solutions Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing number of pharmaceutical and biotechnology companies
3.2.1.2. Growing disease variation and prevalence
3.2.1.3. Increasing R&D investments
3.2.1.4. Growth in the CRO market
3.2.2. Market Restraint Analysis
3.2.2.1. Regulations for new drug development
3.2.2.2. Rising cost of clinical trials
3.3. Clinical Trial Biorepository & Archiving Solutions Market Analysis Tools
3.3.1. Industry Analysis – Porter’s Five Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Clinical Trial Biorepository & Archiving Solutions Market: Service Estimates & Trend Analysis
4.1. Clinical Trial Biorepository & Archiving Solutions Market, By Service: Segment Dashboard
4.2. Clinical Trial Biorepository & Archiving Solutions Market, By Service: Movement Analysis
4.3. Clinical Trial Biorepository & Archiving Solutions Market Estimates & Forecasts, By Service, 2018 – 2030
4.4. Biorepository Services
4.4.1. Biorepository Services Market, 2018 to 2030 (USD Million)
4.4.2. Warehousing & Storage
4.4.3. Transportation
4.4.4. Sample Processing
4.4.5. Others
4.5. Archiving Solution Services
4.5.1 Database Indexing and Management
4.5.2 Scanning & Destruction
Chapter 5. Clinical Trial Biorepository & Archiving Solutions Market: Product Estimates & Trend Analysis
5.1. Clinical Trial Biorepository & Archiving Solutions Market, By Product: Segment Dashboard
5.2. Clinical Trial Biorepository & Archiving Solutions Market, By Product: Movement Analysis
5.3. Clinical Trial Biorepository & Archiving Solutions Market Estimates & Forecasts, By Product, 2018 – 2030
5.4. Preclinical Products
5.5. Clinical Products
5.5.1. Human Tissue
5.5.2. Organs
5.5.3. Stem Cells
5.5.4. Other Biospecimens
Chapter 6. Clinical Trial Biorepository & Archiving Solutions Market: Phase Estimates & Trend Analysis
6.1. Clinical Trial Biorepository & Archiving Solutions Market, By Phase: Segment Dashboard
6.2. Clinical Trial Biorepository & Archiving Solutions Market, By Phase: Movement Analysis
6.3. Clinical Trial Biorepository & Archiving Solutions Market Estimates & Forecasts, By Phase, 2018 – 2030
6.4. Preclinical
6.5. Phase I
6.6. Phase II
6.7. Phase III
6.8. Phase IV
Chapter 7. Clinical Trial Biorepository & Archiving Solutions Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Company Market Share Analysis, 2023/24
8.3. Company Profiles
- Medpace
- American Type Culture Collection (ATCC)
- Cell&Co BioServices (Cryoport)
- Brooks Life Sciences (Azenta, Inc.)
- Patheon (Thermo Fisher Scientific, Inc.)
- Precision Medicine Group, LLC.
- Labcorp Drug Development
- Q2 Solutions
- LabConnect
- Charles River Laboratories
For more information about this report visit https://www.researchandmarkets.com/r/j5qbmq
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Clinical Trial Biorepository & Archiving Solutions Market
